Rajeev M. Shah

Insider Reports History

Entity
Individual
Location
200 Berkeley Street, 18 Th Floor, Boston, MA
Signature
/s/ Thomas P. O'Neil as Attorney in Fact for Rajeev M. Shah
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rajeev M. Shah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kala Pharmaceuticals, Inc. Director Common Stock 10.9M $73.4M $6.74 Jun 17, 2021 Indirect
Kala Pharmaceuticals, Inc. Director Common Stock 20K $135K $6.74 Jun 17, 2021 Direct
Solid Biosciences Inc. Director, 10%+ Owner Director Stock Option (Right to Buy) 30K Jun 16, 2021 Direct
Black Diamond Therapeutics, Inc. Director Stock Option (Right to Buy) 16.5K May 16, 2023 Indirect
Satsuma Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock, $0.0001 par value 0 $0.91 Jun 6, 2023 Indirect
Satsuma Pharmaceuticals, Inc. Director, 10%+ Owner Stock Option (right to buy) 0 Jun 8, 2023 Direct

Insider Reports Filed by Rajeev M. Shah

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STSA Satsuma Pharmaceuticals, Inc. Jun 6, 2023 4 -$5.38M 4 Jun 8, 2023 Director, 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. May 16, 2023 1 $0 4 May 17, 2023 Director
BDTX Black Diamond Therapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 13, 2022 Director
BDTX Black Diamond Therapeutics, Inc. Jun 18, 2021 1 $0 4 Jun 22, 2021 Director
KALA Kala Pharmaceuticals, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director
SLDB Solid Biosciences Inc. Jun 16, 2021 1 $0 4 Jun 21, 2021 Director, 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. May 20, 2021 1 -$10.6K 4 May 21, 2021 Director